[1]
Sköld, C. et al. 2026. Denosumab and bone loss in uncemented total hip arthroplasty: a secondary 5-year follow-up of a randomized controlled trial. Acta Orthopaedica. 97, (Apr. 2026), 217–224. DOI:https://doi.org/10.2340/17453674.2026.45695.